ĀÜĄņĀŅĀ×

The Medical and Scientific Team at Replicate Bioscience focuses on advancing the company's proprietary srRNA technology to address drug resistance in cancers and develop sustained therapeutic protein expression treatments. This team, which includes the Chief Medical Officer and experts in compound development and immuno-oncology, drives clinical strategy, oversees laboratory research, and ensures the scientific integrity of therapeutic innovations.